A nkylosing spondylitis (AS) is an autoimmunerelated rheumatic disease that mainly affects the spine and sacroiliac joints. 1 Spontaneous spinal fusion is the clinical and pathological hallmark of AS, which results from the ankylosis of facet joints and bridging syndesmophytes at the intervertebral disc spaces, ultimately leading to complete loss of the spinal mobility. [2] [3] [4] It has been suggested that the involvement of facet joints might be primarily responsible for the restriction of lumbar mobility and the ankylosis of the spine. [5] [6] [7] In an X-ray study, Jimenez-Balderas et al 8 reported that ankylosed facet joints were present in 21% of the lumbar levels without bridging syndesmophytes, whereas bridging syndesmophytes at a given level without ankylosis of the facet joints were an uncommon finding. Furthermore, the results of 2 computed tomography investigations also showed that impaired spinal mobility highly correlates with radiographic changes, especially in the facet joints of the lumbar spine. 9, 10 These above-mentioned findings imply that the facet joints may be predominantly involved in the process of spinal inflammation, decreasing spinal mobility. Therefore, a detailed investigation of the immunopathology at sites of facet joints is of crucial importance in understanding the pathogenesis of AS, and developing new therapeutic strategies for AS.
To the best of our knowledge, there is only 1 study specifically focusing on immunohistologic analysis of facet joints in AS patients. 11 However, a variety of limitations were found in that study, that is, a relatively small sample size, inappropriate controls using the facet joints from autopsy specimens, age mis-matching between the study group and the control group, and a lack of quantitative analysis of osteoblasts. Therefore, we performed systematic and extensive analysis for the immunopathological changes of the facet joints of AS patients with thoracolumbar kyphosis in a larger sample size in order to identify the different immunohistochemical profiles of facet joints between AS patients and age-matched patients with fresh thoracolumbar fracture.
MATERIALS AND METHODS

Subjects
Between December 2011 and June 2013, a total of 42 facet joints specimens were obtained from 30 AS patients undergoing lumbar pedicle subtraction osteotomy (PSO) for the correction of thoracolumbar kyphosis. The surgical indications were as follows: inability to look straight ahead, sagittal malalignment, and restricted daily life (with the ability to lie down flat in bed, walk, and conduct personal hygiene). Patients with pathological fracture, pseudarthrosis, rheumatoid arthritis, or diffuse idiopathic skeletal hyperostosis were excluded. To obtain satisfactory reconstruction of sagittal alignment and a favorable general back contour, the level of osteotomy was performed at the apical vertebra. 12, 13 As a result, PSO was performed at L1 in 4 patients, at L2 in 21 patients, at L3 in 3 patients, and at L2/ L4 in 2 patients. During the procedure of PSO, either inferior or superior articular processes facet joints or entire facet joints of the osteotomized vertebra were removed for this study. There were 28 male and 2 female patients with an average age of 31.8 years (range, 18-55 yr). The mean disease duration of the AS patients was 11.4 years (range, 3-31 yr), and 90% of them were HLA-B27 positive. The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were also documented. These AS patients had an average thoracolumbar kyphosis of 78 degrees. The thoracolumbar kyphosis was defined as the angle between the superior endplate of the maximally tilted upper end vertebra and the inferior endplate of the maximally tilted lower end vertebra on the full-length lateral radiographs. 14 In addition, lumbar spinal mobility was assessed using modified Schober index (MSI). 15 A higher MSI score was indicative of decreased lumbar mobility. Lateral radiographs of the entire spine were scored using the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS). According to this method, the anterior vertebral corners (VCs) of the cervical and lumbar segments (total of 24 VCs) are scored on a lateral view only for the presence of an erosion and/or sclerosis and/or squaring (1 point), syndesmophyte (2 points), and bridging syndesmophyte (3 points). The total score ranges from 0 to 72. 5 The demographic and clinical characteristics of AS patients and controls are summarized in Table 1 . Of the 30 AS patients, 16 (53.3%) were taking nonsteroidal anti-inflammatory drugs, and 3 (10%) were receiving other disease-modifying anti-rheumatic drugs.
The control samples were taken from 23 patients with fresh traumatic thoracolumbar fracture who underwent decompressive surgery due to neurological deficits. No inflammatory disorders were identified in these patients. The fracture levels for the 23 patients (20 males and 3 females) studied were T12 in 6, L1 in 13, and L2 in 4. The mean age of the patients with thoracolumbar fracture was 33.2 years (range, 21-49 yr).
Facet joints were fixed in 4% buffered formalin and decalcified using 20% ethylene diamine tetraacetic acid (EDTA). Sections were embedded in paraffin and cut into slices (4-6 m thick) using a microtome (Leica). Sections were deparaffinized and hydrated, followed by an antigen-retrieval process consisting of 5 minutes of heating and submersion in Tris-EDTA-based pH 9 retrieval-solution (Dako, Glostrup, Denmark) using a high-pressure cooker. Immunofluorescence staining with specific monoclonal antibodies (mAb) was performed using a routine 3-stage immuno-alkaline phosphatase labeling technique incorporating labeled streptavidinbiotin complex (LSAB kit; Vector Laboratories, Burlingame, CA). Cell nuclei were counterstained with hematoxylin and eosin or diamidino-phenyl-indole. Stained sections were examined by an attending pathologist. The study was approved by the ethical committee at our hospital.
Immunohistochemistry
Immunohistochemistry analysis of the bone marrow was performed to detect CD3þT cells, CD4þT cells, CD8þT cells, CD20þ B cells, CD34þ microvessels, CD68þ macrophages, CD56þ osteoblasts, and CD68þ osteoclasts using the VECTASTAIN ABC kit (Vector Laboratories, Burlingame, CA). In brief, tissue sections were immersed in a sodium citrate buffer solution at pH 6.0 and heated in a high-pressure cooker for 2 minutes (CD4, CD8, CD20, and CD56), 5 minutes (CD3) and 10 minutes (CD34 and CD68). After cooking, the slides were rinsed in cool running water, washed in Tris-buffered saline (pH 7.4), and incubated with the respective primary antibodies including mAbs against CD3 (clone SP7, 1:200 dilution; abcam, Cambridge, UK), CD4 (dilution 1:100; abcam, Cambridge, UK), CD8 (C8/ 144B, dilution 1:100; Dako, Glostrup, Denmark), CD20 (clone L26, 1:50 dilution; abcam, Cambridge, UK), CD34 (dilution 1:100; abcam, Cambridge, UK), CD56 (1B6, dilution 1:50; Monosan, Uden, The Netherlands), and CD68 (PG-M1, dilution 1:50; abcam, Cambridge, UK). Then, the tissues were incubated with a biotinylated secondary Ab and a streptavidin-peroxidase complex for 1 hour. The final colored product was developed using DAB Chromogen (Thermo Fisher Scientific, Waltham, MA). In addition, histochemical tartrate-resistant acid phosphatase (TRAP) staining (Sigma-Aldrich, Taufkirchen, Germany) for the specific detection of osteoclasts was performed because CD68 is not exclusively expressed on osteoclasts.
As described in the literature, 16 more than 50 CD3þ T cells per hpf was considered to be a lymphocytic aggregate. Similarly, a CD68þ osteoclastic focus was defined as !5 multinuclear osteoclasts per hpf. The total numbers of lymphocytic aggregate and CD68þ osteoclastic foci were expressed as 10 hpf. The numbers of CD4þ, CD8þ, CD20þ, CD68þ, CD56þ, CD34þ cells were expressed as mean value per hpf after analyzing 10 HPFs.
Statistical Analysis
The data were analyzed using SPSS version 17.0 software (SPSS Inc, Chicago, IL). The differences in the number of lymphocytes, microvessels density, osteoblasts, osteoclasts, and macrophages between the groups were evaluated using Kruskal-Wallis test, and the differences in ESR, CRP, and MSI score between the groups were analyzed using independent-samples t test. A value of P < 0.05 was considered to be statistically significant.
RESULTS
With respect to the lymphocytic aggregates, 18 of 30 AS patients had !2 CD3þ T cell aggregates per 10 hpf ( Figure 1A) , with a breakdown as follows: 2 aggregates in 4 patients, 3 aggregates in 6 patients, 5 aggregates in 6 patients, 6 aggregates in 2 patients, while 1 CD3þ T cell aggregate was found in the facet joints of 5 controls ( Figure 1B) . Depending on the number of 2 CD3þ T cell aggregates, all AS patients were divided into 2 groups (group A, 18 patients with persistent inflammation (!2 CD3þ T cell aggregates per 10 hpf) 11 and group B, 12 patients without persistent inflammation).
Significant difference was noted between group A and group B in terms of ESR (38AE 12.8 vs. 12.2 AE 3.7 mm/h; P < 0.01), CRP (34 AE 18.5 vs. 7.2AE 3.1 mg/L; P < 0.01), and mSASSS (25.6 AE 16.7 vs. 18.2 AE 9.6; P < 0.01), but no difference in disease duration was identified (14.2 AE 5.6 vs. 13.7 AE 11.3 yr; P ¼ 0.873). Of note, compared with group B, the MSI score was higher in group A (1.8 AE 0.4 vs. 1AE 0.7; P ¼ 0.0004), indicating that the patients in group A had significantly decreased lumbar spinal mobility compared with those in group B.
Lymphocytes
Compared with the controls, the AS group was observed to have significantly higher levels of CD4þ T cells (11.8 AE 2.81 vs. 7 AE 1.03 hpf; P < 0.01) (Figures 2A, B, and 3) , CD8þ T cells (9 AE 3.77 vs. 5 AE 0.88 per hpf; P < 0.01) ( Figure 2C , D, and 3), and CD20þ B (12.7 AE 6.32 vs. 5.3 AE 0.89 hpf; P < 0.01) ( Figure 2E , F, and 3) in the bone marrow of facet joints. The AS patients with persistent inflammation showed increased levels of CD4þ T cells (14.8 AE 1.52 hpf), CD8þ T cells (10.1 AE 1.06 hpf), and CD20þ B cells (13.5 AE 1.07 hpf) when compared with the patients without persistent inflammation (CD4þ T cells, 9.6 AE 0.86 hpf, P < 0.01; CD8þ T cells, 7.3 AE 0.54 hpf, P < 0.01; CD20þ B cells, 6.1 AE 0.71 hpf, P < 0.01) and the controls (CD4þ T cells, 7.0 AE 1.03 Figure 2 . Immunohistochemical demonstration of lymphocytes in bone marrow of the facet joints (original magnification x400). A (AS, yellow arrow) and B (control, red arrow), CD4þ T cells; C (AS, yellow arrow) and D (control, red arrow), CD8þ T cells; E (AS, yellow arrow) and F (control, red arrow), CD20þ B cells. hpf, P < 0.01; CD8þ T cells, 5 AE 0.88 hpf, P < 0.01; CD20þ B cells, 5.3 AE 0.89 hpf, P < 0.01) (Figure 3 ). Moreover, CD4þ T cells, CD8þ T cells, and CD20þ B cells were significantly more frequent in the patients without persistent inflammation than controls (CD4þ T cells, 9.6 AE 0.86 vs. 7 AE 1.03 hpf, P < 0.01; CD8þ T cells, 7.3 AE 0.54 vs. 5 AE 0.88 per hpf, P < 0.01; CD20þ B, 6.1 AE 0.71 vs. 5.3 AE 0.89 hpf, P ¼ 0.01) (Figure 3 ). Notably, 2 or more CD20þ B cell aggregates were found in the facet joints of 3 AS patients, which were located within the T cell aggregates.
Microvessels Density and Osteoblasts
Compared with the controls, microvessel density ( Figures  4A, B , and 5) and osteoblasts ( Figure 4C , D, and 5) were significantly increased in the bone marrow of facet joints of the AS patients (microvessels density, 5.6 AE 0.82 vs. 1.8 AE 0.41 hpf, P < 0.01; osteoblasts, 4.3 AE 0.58 vs. 3.9 AE 0.29 hpf, P ¼ 0.004). Significantly higher numbers of microvessels and osteoblasts were observed in both subgroups of the AS patients than in the controls (all P < 0.01) ( Figure 5 ). However, no significant difference was noted between the AS patients with and without persistent inflammation in terms of microvessel density ( Figure 5 ). In contrast, osteoblasts differed significantly between the AS patients with and those without persistent inflammation (4.6 AE 0.37 vs. 4 AE 0.51 hpf; P ¼ 0.0008) ( Figure 5 ).
Osteoclasts and Macrophages
No significant differences were observed between the AS patients and the controls with respect to osteoclasts (P ¼ 0.21) and macrophages (P ¼ 0.36). Similarly, there were no significant differences between the AS patients (either with or without persistent inflammation) and the controls (P ¼ 0.54; P ¼ 0.32, respectively). In addition, osteoclasts and macrophages did not differ significantly between the AS patients with and without persistent inflammation (P ¼ 0.16; P ¼ 0.47, respectively).
DISCUSSION
AS is a chronic inflammatory arthritis that is characterized by new bone formation, syndesmophytes along with the intervertebral disc spaces, and ankylosis of the vertebral column, which result in impairment of spinal mobility. 1 Limited spinal mobility is a cardinal sign of AS, featured strongly in the modified New York Criteria. 17 Moreover, the Assessment in Ankylosing Spondylitis international group (ASAS) has recommended spinal mobility as a core domain in the evaluation of patients with AS. 18 Both for clinical practice and for study purposes, it is of the utmost importance to know what factors result in the loss of spinal mobility in AS. As reported in several previous studies, 5-7 structural damage in facet joints may be mainly involved in impaired spinal mobility. Therefore, a thorough investigation of pathogenic mechanisms of ankylosis of facet joints may help develop early therapeutic strategies to reduce loss of spinal mobility in AS patients.
To date, only 1 study investigated immunopathology of the facet joints in AS patients, and the results of the study revealed persistent inflammation and an increase in the number of T cells, B cells, and neoangiogenesis in the spine of AS patients. 11 However, the strengths of the study were weakened by several limitations described previously. To remedy these issues, the present study was conducted to comprehensively analyze the immunopathology of the facet joints from AS patients with thoracolumbar kyphosis.
In the current study, immunohistochemistry was performed in 30 AS patients and 23 controls, and the results demonstrated that persistent inflammation (facet joints with !2 CD3þ T lymphocytic aggregates per 10 hpf) in the bone marrow of facet joints was observed in 18 of 30 AS patients with thoracolumbar kyphosis, suggesting that significant spinal inflammation is still present in a substantial proportion of AS patients with a long-standing disease and advanced ankylosis. Furthermore, patients with persistent inflammation demonstrated decreased lumbar spinal mobility and higher mSASSS scores than those without persistent inflammation. Therefore, spinal inflammation should be routinely monitored in advanced stages of AS patients to prevent loss of spinal mobility to some extent.
In addition, significantly increased frequencies of CD4þT cells, CD8þT cells, and CD56þ osteoblasts were detected in patients with persistent inflammation when compared with patients without persistent inflammation (all P < 0.01). Compared with controls, the number of CD4þT cells, CD8þT cells, and CD56þ osteoblasts in all AS patients was significantly higher (all P < 0.01). These findings further support the previous hypothesis that T cells play a key role in the pathogenesis of AS, and inflammation stimulates osteoblasts activation, leading to excessive bone formation. [19] [20] [21] [22] Historically, very few studies have focused on the role of B cells in AS, most likely because in contrast to systemic lupus, erythematous, or rheumatoid arthritis, autoantibodies did not appear to be involved in the development of AS. 19, 23 However, there is emerging evidence that B cells may also play a critical role in the pathological mechanism of AS. In a series of 30 patients with spondylarthritis treated by anti-tumor necrosis factor a (TNFa), Kruithof et al 24 found that the effect of infliximab on the B cell lineage was less pronounced than on the T lymphocytes, macrophages, and neutrophils, which might explain the reason that relapses occur soon after anti-TNFa therapy has been discontinued, indicating a possible role of B cells in the immunopathology of AS. In addition, Cunnane et al 25 reported significantly increased numbers of B cells in the synovial membrane of 2 AS patients with peripheral joint involvement. Of note, a recent study conducted by Appel et al 11 demonstrated a significant increase in the number of CD20þ B cells in the facet joints of AS patients with persistent inflammation compared with AS patients without inflammation and controls. In our study, not only was the number of CD20þ B cells in the facet joints of the patients with persistent inflammation significantly higher than in the patients without persistent inflammation and the controls, but also the frequency of CD20þ B cells in all AS patients was noted to be significantly increased compared with the controls. Moreover, an increased number of CD20þ B cells were always accompanied by T cell aggregates, which confirms the notion that in addition to serving as antibody-producing plasma cells, B cells can act as both ILproducing cells and antigen-presenting cells, facilitating the activation of T cells. Therefore, further investigations are needed to elucidate the precise role of B cells in the induction of autoimmune inflammatory response in AS, which may help to understand the new aspect of AS pathogenic mechanisms, as well as design new therapeutic strategy targeting B cells to improve the effectiveness of AS treatment.
Another noteworthy finding of the present study was the demonstration of increased density of microvessel in AS patients. This was independent of persistent inflammation, that is, there was no difference noted between patients with persistent inflammation and those without persistent inflammation. More importantly, these microvessels were noted not only close to lymphocytic infiltrates but also at the sites of new bone formation, suggesting that neoangiogenesis plays a vital role in both acute inflammation and new bone formation. Of interest, recent studies have demonstrated that vascular endothelial growth factor (VEGF), a key factor in neoangiogenesis, might be relevant for AS. Lin et al 26 reported that a higher serum VEGF level was found to be associated with disease activity in AS patients. Moreover, Poddubnyy et al 27 found that an elevated serum level of VEGF (>600 pg/mL) is highly specific as a predictor of radiographic spinal progression in patients with axial spondyloarthritis, especially in patients who are at a high risk for further progression due to the presence of syndesmophytes. On the basis of these aforementioned observations, inhibition of VEGF expression may be effective in improving inflammation while simultaneously preventing new bone formation in AS patients. Thus, the role of VEGF in AS should also be extensively investigated in future studies, which may provide a novel therapeutic target for AS.
Two limitations of our study should be mentioned. Firstly, different drug treatments used in the investigated patients might have had an impact on the levels of T cells (CD4þ and CD8þ), CD20þB cells, CD56þ osteoblasts, and CD34þ microvessel density. Hence, further studies would be needed to elucidate this effect. Despite this limitation, the strengths of our study include its relatively large sample size and use of age-matched patients with fresh thoracolumbar fracture as controls. Furthermore, to our knowledge, this is the first study to evaluate the relationship between the immunopathology of the facet joints and lumbar spinal mobility. Secondly, the current study was crosssectional but not longitudinal, which was insufficient to tell when the peak of inflammation was most profound in the mature patient with AS. Besides, it was barely possible and immoral for an immunohistochemical study to perform repetitive harvest of bone tissue for each patient. Thus, further studies using serum markers of inflammation, ESR or CRP, for example, could be suggested to alternatively monitor the dynamic fluctuation of inflammation level and subsequently identify the peak. This should be a point of focus in our future study.
In summary, the results of this study show that even in patients with later stages of AS, inflammatory activity is still present in the spine and may further impair spinal mobility, suggesting that it is necessary to monitor the disease activity for these patients. In addition, the increased number of T cells, B cells, neoangiogenesis, and osteoblasts observed in our study adds support to the notion that multiple mechanisms are involved in the pathogenesis of AS.
Key Points
The increased number of T cells, B cells, neoangiogenesis, and osteoblasts observed in our study adds support to the notion that multiple mechanisms are involved in the pathogenesis of AS. Active spinal inflammation is frequently observed in AS patients with thoracolumbar kyphosis. In addition, persistent inflammation in facet joints may further contribute to the loss of spinal mobility in the later stages of AS. These findings indicate that careful monitoring of disease activity is mandatory for AS patients in its advanced stage.
